The Euro­pean Coun­cil rec­om­mends an expan­sion of can­cer screen­ing in the EU – the pro­pos­al is an update of the 2003 Coun­cil Rec­om­men­da­tion on the screen­ing of breast, cer­vi­cal and col­orec­tal can­cers. The doc­u­ment now also encom­pass­es objec­tives to cov­er lung, pros­trate and gas­tric can­cers. Fur­ther­more, it extends breast can­cer age range and updates the screen­ing tests for use in breast, col­orec­tal and cer­vi­cal cancer. 

The back­ground for this step is that over the past twen­ty years, there has been extra­or­di­nary progress in med­i­cine but at the same time sig­nif­i­cant incon­sis­ten­cies in screen­ing ser­vices around the EU. As a mat­ter of fact, 7 mil­lion peo­ple were diag­nosed with can­cer, and anoth­er 1.3 mil­lion died from can­cer in 2020. Deaths by can­cer are expect­ed to increase by 24% by 2035, mak­ing it the chief rea­son of death in the region. It is esti­mat­ed that new can­cer cas­es will rise by 21% and death due to can­cer will rise by 31% by 2040, unless cru­cial action is tak­en immediately. 

Source: Medtech Insight (an Infor­ma product)

Accom­pa­ny­ing this sub­ject we rec­om­mend the fol­low­ing con­tent on our website

Browse by key­word “Euro­pean Commission”